Home/Filings/4/0001104659-22-067099
4//SEC Filing

Dudley Robert Michael 4

Accession 0001104659-22-067099

CIK 0001829635other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:01 PM ET

Size

6.0 KB

Accession

0001104659-22-067099

Insider Transaction Report

Form 4
Period: 2022-05-27
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2022-05-27$1.84/sh+28,000$51,643871,114 total
  • Purchase

    Common Stock

    2022-05-31$1.87/sh+2,000$3,740873,114 total

Issuer

Transcode Therapeutics, Inc.

CIK 0001829635

Entity typeother

Related Parties

1
  • filerCIK 0001854161

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:01 PM ET
Size
6.0 KB